Mustafa Khasraw
Overview:
I am a medical oncologist, neuro-oncologist, tenured professor of medicine and neurooncology, and Deputy Director of the Center for Cancer Immunotherapy, Duke Cancer Institute, where we are tasked to speed up clinical research and translation for scientists across all departments and all tumor types at Duke, who have made discoveries that show promise for developing new immunotherapies.
I am leading clinical and translational programs with laboratory collaborations with an interest in innovative trials designed to improve the outcome of patients with cancers of the CNS.
I serve as an advisor and grant reviewer for several non-profits and patient advocacy groups. I am a Fellow of the Royal Australasian College of Physicians and an Elected Fellow of the Royal College of Physicians (UK).
Positions:
Professor of Neurosurgery
Professor in Medicine
Member of the Duke Cancer Institute
Education:
M.D. 2001
Grants:
Astellas 1951-CL-0101
Celldex CDX-527
A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiform (WHO Grade IV) After Failure of Standard First Line
Phase 1 BNT152+153 in patients with solid tumors
PARAMETer: A window of opportunity study of Patritumab Deruxtecan in patients with brain metastases
Publications:
Intra-aortic metastases or intra-arterial thrombus?
Anti-angiogenic therapy for lung cancer
Management of glioblastoma: an Australian perspective.
Patterns of care in adult histone mutant gliomas: Results of an international survey.
EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms.
Research Areas:
